Brompheniramine tannate 4 mg / phenylephrine tannate 5 mg in 5 mL Extended Release Suspension
RxNorm 616351
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 616351 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: brompheniramine tannate 4 mg / phenylephrine tannate 5 mg in 5 mL Extended Release Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Brompheniramine tannate 0.8 mg/ML / phenylephrine tannate 1 mg/ML Extended Release Suspension
(Atom ID: 12350779)
PSN
Prescribable Name (PSN):
Brompheniramine tannate 4 mg / phenylephrine tannate 5 mg in 5 mL Extended Release Suspension
(Atom ID: 13049887)
SY